Your results for

Filter by

Filter by
Results

Filter by

Content type
Key content topics
Key audience
Top cancer treatments

Hypofractionated Proton Therapy With Concurrent Chemotherapy for Locally Advanced Non-Small Cell Lung Cancer: A Phase I Trial From the University of Florida and Proton Collaborative Group.

03/04/2020
/ Publications
/
Hypofractionation
Chemotherapy

Published in the Red Journal, this study reported the safety data from the first multicenter phase I trial investigating the use of hypofractionated proton...

Phase II Study of Hypofractionated Proton Beam Therapy for Hepatocellular Carcinoma.

28/04/2020
/ Publications
/
Hypofractionation
Survival
Toxicity

Published by the NCC group in Korea, this study reported outcomes of 45 patients including 37 had recurrent and/or residual disease treated with PBT to a total...

Hypofractionated proton beam radiotherapy in patients with unresectable liver tumors: multi-institutional prospective results from the Proton Collaborative Group.

10/11/2020
/ Publications
/
Hypofractionation

This study analyzed the data of 63 patients with liver tumors treated with PBT. Hypofractionated PBT resulted in excellent local control, sparing of the...

Image-Guided Hypofractionated Proton Therapy in Early-Stage Non-Small Cell Lung Cancer: A Phase 2 Study.

10/11/2020
/ Publications
/
Hypofractionation
Survival

22 patients with T1 to T2 N0M0 NSCLC received image-guided hypofractionated PBT to a total dose 48 GyRBE in 4 fractions for peripheral lesions and 60 GyRBE in...

Extreme hypofractionated proton radiotherapy for prostate cancer using pencil beam scanning: Dosimetry, acute toxicity and preliminary results.

07/09/2019
/ Publications
/
Hypofractionation
Pencil Beam Scanning - PBS

A study by the research group in Prague. Two hundred patients with early-stage prostate cancer were treated with IMPT on extreme hypofractionated schedule (36...

Post-mastectomy IMPT after immediate breast reconstruction

03/06/2019
/ Publications
/
Hypofractionation

Published in the Green Journal, the Mayo Clinic group reported outcomes of 51 women among who 42 had bilateral reconstruction treated with unilateral IMPT...

Hypofractionated PBT for centrally located lung cancer.

03/05/2019
/ Publications
/
Hypofractionation

This study from Japan reported outcomes of 39 patients who received hypofractionated PBT for centrally located cT1-2N0M0. Twenty-four patients (62%) were...

Initial toxicity, QoL outcomes, and dosimetric impact in a randomized phase 3 trial of hypofractionated vs. standard fractionated PT for low-risk prostate cancer

08/02/2018
/ Publications
/
Hypofractionation
Quality of life

A multi-center prospective phase 3 randomized trial aimed to identify differences in toxicity and quality-of-life outcomes between standard fractionation and...

Cost effectiveness of prostate cancer radiotherapy.

08/06/2018
/ Publications
/
IMRT
Hypofractionation

This review article by Konski A, examined the data of cost-effectiveness analyses of various radiotherapy modalities including 3DCRT, IMRT, hypofractionated RT...

Acute toxicity of image-guided hypofractionated proton therapy for localized prostate cancer.

11/11/2017
/ Publications
/
Hypofractionation

A study reported toxicity of 526 localized prostate cancer patients treated with proton therapy and demonstrated the safety of HFPT for localized PCa patients...